Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials

HIV Medicine- United Kingdom

doi 10.1111/hiv.12664

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (FTC/TAF) vs. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by Third Agent of a Randomized, Double-Blind, Active-Controlled Phase 3 Trial

HIV Clinical Trials
2017English

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2020English

First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

O015 Establishment of a Monitoring Service for Men Who Have Sex With Men (MSM) Taking Generic Co-Formulated Tenofovir Disoproxil Fumarate (TDF)/emtricitabine (FTC) as Pre-Exposure Prophylaxis (PrEP) Against HIV Infection

Sexually Transmitted Infections
DermatologyInfectious Diseases
2016English

Switch From Tenofovir Disoproxil Fumarate Combination to Dolutegravir Plus Rilpivirine Improves Parameters of Bone Health

AIDS
Infectious DiseasesAllergyImmunology
2017English

Emtricitabine, Tenofovir, and Rilpivirine From Their Degradation Products Analysis by HPLC

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2019English

In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir With Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Verxve 144-Week Results: Nevirapine Extended Release (NVP XR) Qd Versus NVP Immediate Release (IR) Bid With FTC/TDF in Treatment-Naive HIV-1 Patients

Journal of AIDS & Clinical Research
2013English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy